CureVac N.V.
NASDAQ:CVAC
2.84 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Assets: | ||||||
Current Assets: | ||||||
Cash & Cash Equivalents
| 402.784 | 495.797 | 811.464 | 1,322.593 | 30.684 | 21.38 |
Short Term Investments
| 2.661 | 4.487 | 4.648 | 2.619 | 1.458 | 39.253 |
Cash and Short Term Investments
| 402.784 | 500.284 | 816.112 | 1,325.212 | 32.142 | 60.633 |
Net Receivables
| 35.921 | 39.437 | 18.504 | 1.822 | 17.686 | 6.858 |
Inventory
| 24.821 | 23.989 | 56.159 | 14.531 | 6.197 | 2.951 |
Other Current Assets
| 15.25 | 5.345 | 49.244 | 48.289 | 1.15 | 2.628 |
Total Current Assets
| 478.775 | 584.029 | 940.019 | 1,389.854 | 57.175 | 73.07 |
Non-Current Assets: | ||||||
Property, Plant & Equipment, Net
| 278.855 | 241.702 | 200.393 | 104.791 | 66.78 | 45.493 |
Goodwill
| 12.473 | 12.463 | 0 | 0 | 0 | 0 |
Intangible Assets
| 15.882 | 19.315 | 13.238 | 14.146 | 5.698 | 6.213 |
Goodwill and Intangible Assets
| 28.345 | 31.778 | 13.238 | 14.146 | 5.698 | 6.213 |
Long Term Investments
| 15.897 | 0 | 0.515 | 1.034 | 0 | 0.749 |
Tax Assets
| 1.195 | 1.297 | 2.861 | 0.445 | 0 | 0.133 |
Other Non-Current Assets
| -14.168 | 1.666 | 1.216 | 1.086 | 0.967 | 0.001 |
Total Non-Current Assets
| 310.123 | 276.443 | 218.223 | 121.502 | 73.445 | 52.589 |
Total Assets
| 788.899 | 860.472 | 1,158.242 | 1,511.356 | 130.62 | 125.659 |
Liabilities & Equity: | ||||||
Current Liabilities: | ||||||
Account Payables
| 46.403 | 68.246 | 122.263 | 17.623 | 5.331 | 9.029 |
Short Term Debt
| 5.009 | 4.98 | 3.469 | 3.234 | 2.004 | 0.217 |
Tax Payables
| 0.655 | 1.534 | 1.663 | 12.66 | 0.111 | 0.217 |
Deferred Revenue
| 44.617 | 36.78 | 55.75 | 157.985 | 7.481 | 5.777 |
Other Current Liabilities
| 90.514 | 46.219 | 176.252 | 68.78 | 13.27 | 13.107 |
Total Current Liabilities
| 186.543 | 156.225 | 357.734 | 247.622 | 28.086 | 28.13 |
Non-Current Liabilities: | ||||||
Long Term Debt
| 36.819 | 37.106 | 25.423 | 26.853 | 77.144 | 0 |
Deferred Revenue Non-Current
| 48.14 | 72.549 | 86.345 | 500.061 | 66.04 | 64.583 |
Deferred Tax Liabilities Non-Current
| -48.07 | 0 | 0 | 0 | 1.623 | 0 |
Other Non-Current Liabilities
| 48.1 | 61.339 | 0.264 | 25.473 | 0.529 | 0.863 |
Total Non-Current Liabilities
| 84.989 | 170.994 | 112.032 | 552.387 | 145.336 | 65.446 |
Total Liabilities
| 271.532 | 327.219 | 469.766 | 800.009 | 173.422 | 93.576 |
Equity: | ||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 26.901 | 23.4 | 22.454 | 21.655 | 0.727 | 0.727 |
Retained Earnings
| -1,567.272 | -1,305.814 | -1,056.785 | -645.069 | -515.947 | -416.074 |
Accumulated Other Comprehensive Income/Loss
| -0.067 | 1,817.148 | 1,728.624 | 1,334.761 | 472.418 | 447.43 |
Other Total Stockholders Equity
| 2,057.805 | -1.481 | -5.817 | 0 | 0 | 0 |
Total Shareholders Equity
| 517.367 | 533.253 | 688.476 | 711.347 | -42.802 | 32.083 |
Total Equity
| 517.367 | 533.253 | 688.476 | 711.347 | -42.802 | 32.083 |
Total Liabilities & Shareholders Equity
| 788.899 | 860.472 | 1,158.242 | 1,511.356 | 130.62 | 125.659 |